On 1 November 2019, Leuka and Leukaemia UK merged, bringing together two of the UK’s leading leukaemia and blood cancer charities to create one charity dedicated to innovative research and care for people affected by blood cancers. 

The two charities joined forces under the name Leukaemia UK, uniting Leuka’s 37 years’ experience in ground-breaking medical research with Leukaemia UK’s four decades of pioneering care.  

Some key milestones in Leukaemia UK’s history include: 

2005 - The Catherine Lewis Centre at Hammersmith Hospital opens a new facility for processing blood and bone marrow stem cells for transplantation. A dedicated Clinical Trials Unit opens to study new drugs and pioneer therapies for leukaemia 

2015 - Leuka launches a new initiative – the John Goldman Fellowships for Future Science Awards.

2016 - Leuka invests £1m in a major new UK platform for stem cell transplantation patients. The project, called IMPACT, aims to accelerate the delivery of prospective clinical trials to improve outcomes for eligible patients. Partners include NHSBMT, Anthony Nolan and the University of Birmingham.  

2018 – The Leukaemia UK Ambulatory Care unit opens at King’s College Hospital, London, providing access to conditioning and stem cell treatments on an outpatient basis for certain patient groups.  

2018 – Leukaemia UK’s Early Career research grant programme launches, supporting researchers and clinicians around the UK to undertake small but innovative research projects. 

From research to care, we put people affected by leukaemia and other blood cancers at the heart of what we do.  

Leukaemia UK is led by Fiona Hazell, who joined as CEO in September 2020. The charity's Chair of Trustees is Chris Corbin, previously Chair of Leuka, who is supported by a Board of Trustees. 

Thanks to research, leukaemia survival is improving and has more than quadrupled in the past 40 years in the UK. But we know we need to do more to accelerate research and change the lives of more people affected by leukaemia.  

We are continuing to fund world-class research with the aim of developing kinder and more effective treatments. 

Read our FAQs document about our merger

More about Leuka's history

More about Leukaemia UK's history prior to its merger with Leuka

Leukaemia UK's office address is: Leukaemia UK, 52 Portland Place, London, W1B 1NH.

We are extremely grateful to the David Coffer Lyons for generously allowing Leukaemia UK to use their 52 Portland Place office as our main office.

Leukaemia UK relies entirely on your voluntary donations. Find out how to support us continue our important work.